Adrenal Insufficiency

Endocrinology: Adult and Pediatric, Sixth Edition

Volumn 2, Issue , 2010, Pages 1853-1863

  Chung, Teng Teng ^a   Grossman, Ashley ^b   Clark, Adrian J L ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80053903980     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-5583-9.00101-5     Document Type: Chapter

References (126)

1. K Lovas and ES Husebye (2002) High prevalence and increasing incidence of Addison's disease in western Norway. Clin Endocrinol 56 787-791.
2. MF Kong and W Jeffcoate (1994) Eighty-six cases of Addison's disease. Clin Endocrinol 41 757-761.
3. B Eustachi and G Fallopio (1563) Opuscula Anatomica. Venice: M.A. Ulmus
4. T Addison (1855) On the Constitutional and Local Effects of Disease of the Suprarenal Capsules. London: Highly
5. CE Brown-Sequard (1856) Recherches experimentales sur la physiologie et la pathologie des capsules surrenales. Acad Sci Paris 43 422-425.
6. A Trousseau (1856) Bronze Addison's disease. Arch Gen Med 8 478.
7. W Osler (1896) Case of Addison's disease: death during treatment with the supravital extra. Bull Johns Hopkins Hosp 7 208-209.
8. OP Wintersteiner and J Pfiffner (1935) Chemical studies on the adrenal cortex: II. J Biol Chem 111 599-612.
9. EC Kendall (1937) A chemical and physiological investigation of the suprarenal cortex. Symp Quant Biol 5 299.
10. P de Fremery, E Laquer, T Reichstein, et al. (1937) Corticosterone: a crystalloid compound with biological activity of the adrenal-cortical hormone. Nature 139 26-27.
11. A Grollman (1937) Physiological and chemical studies on the adrenal cortical hormone. Symp Quant Biol 5 313.
12. L Sarett (1946) The synthesis of hydrocortisone from desoxycholic acid. J Biol Chem 162 601.
13. PS Hench, CH Slocumb, AR Barnes, et al. (1949) The effects of the adrenal cortical hormone, compound E, on the acute phase of rheumatic fever: a preliminary report. Proc Mayo Clin 24 277-297.
14. GW Thorn and PH Forsham (1949) The treatment of adrenal insufficiency, Rec Prog. Horm Res 4 229.
15. HW Cushing (1912) The Pituitary Body and Its Disorders. Philadelphia: JB Lippincott
16. GW Harris (1948) Neural control of the pituitary gland. Physiol Rev 28 139.
17. CH Li, JS Dixon and D Chung (1958) The structure of bovine corticotropin. J Am Chem Soc 80 2587-2596.
18. W Vale, J Spiers, C Rivier, et al. (1981) Characterization of a 41 residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 213 585-587.
19. PA Sampson, BN Brooke and NE Winstone (1961) Biochemical confirmation of collapse due to adrenal failure. Lancet 1 1377.
20. RJ Speigel, RA Vigersky and AI Oliff (1979) Adrenal suppression after short term corticosteroid therapy. Lancet 1 630-632.
21. JM Olefsky (1975) The effect of dexamethasone on insulin binding, glucose transport, and glucose oxidation of isolated rat adipocytes. J Clin Invest 56 1499-1508.
22. MM Reidenberg, EA Ohler, RW Seuy, et al. (1963) Hemodynamic changes in adrenalectomized dogs. Endocrinology 72 918-923.
23. APW Clarke, RA Cleghorn, JKW Ferguson, et al. (1947) Factors concerned in the circulatory failure of adrenal insufficiency. J Clin Invest 26 359-363.
24. AM Lefer, RL Verrier and WW Carson (1968) Cardiac performance in experimental adrenal insufficiency. Circ Res 22 817-827.
25. SB Rodan and GA Rodan (1986) Dexamethasone effects on beta-adrenergic receptors and adenylate cyclase regulatory proteins Gs and Gi in ROS 17/2.8 cells. Endocrinology 118 2510-2518.
26. JN Livingstone and DH Lockwood (1975) Effect of glucocorticoids on the glucose transport system of isolated fat cells. J Biol Chem 250 8353-8360.
27. D Marver and JP Kokko (1983) Renal target sites and the mechanism of action of aldosterone. Miner Electrolyte Metab 9 1-32.
28. M Neufeld, N MacLaren and R Blizzard (1980) Autoimmune polyglandular syndromes. Pediatr Ann 9 154-162.
29. C Betterle, NA Greggio and M Valpato (1998) Clinical review 93: autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab 83 1049-1055.
30. C Betterle, M Valpato, NA Greggio, et al. (1996) Type 2 polyglandular autoimmune disease (Schmidt's syndrome). J Pediatr Endocrinol Metab 9 113-123.
31. M Dittmar and GJ Kahaly (2003) Extensive personal experience. Polyglandular autoimmune syndromes: immunogenetics and Long-Term follow up. J Clin Endocrinol Metab 88 2983-2992.
32. GS Eisenbarth, PN Wilson, F Ward, et al. (1979) The polyglandular failure syndrome: disease inheritance, HLA-type, and immune function studies in patients and families. Ann Intern Med 91 528-533.
33. D Devendra and GS Eisenbarth (2003) Immunologic endocrine disorders. J Allergy Clin Immunol 111 S624-S636.
34. G Coco, C Dal Pra, F Presotto, et al. (2006) Estimated Risk for Developing Autoimmune Addison's Disease in Patients with Adrenal Cortex Autoantibodies. J Clin Endocrinol Metab 91 1637-1645.
35. C Betterle, C Dal Pra, F Mantero, et al. (2002) Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction. Endocr Rev 23 327-364.
36. M Neufeld, NK Maclaren and RM Blizzard (1981) Two types of autoimmune Addison's disease associated with different polyglandular autoimmune syndromes. Medicine 60 355-362.
37. P Ahonen, S Myllärniemi, I Sipilä, et al. (1990) Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med 322 1829-1836.
38. An autoimmune disease, APECED, caused by mutations in a novel gene featuring two PHD-type zinc-finger domains: Finnish-German APEED Consortium. Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy. Nat Genet 17 399-403.
39. K Nagamine, P Peterson, HS Scott, et al. (1997) Positional cloning of the APECED gene. Nat Genet 17 393-398.
40. J Perheentupa (2002) APS1/APECED: the clinical disease and therapy. Endocrinol Metab Clinic North Am 31 295-320.
41. SH Pearce and TD Cheetham (2001) Autoimmune polyendocrinopathy syndrome type 1: treat with kid gloves. Clin Endocrinol (Oxf) 54 433-435.
42. JM Barker and GS Eisenbarth (2003) Autoimmune polyendocrine syndromes. GS Eisenbarth,(Eds) Type 1 diabetes: molecular, cellular, and clinical immunology Denver: Barbara Davis Center for Childhood Diabetes (Web only)
43. A Söderbergh, AG Myhre, O Ekwall, et al. (2004) Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 89 557-562.
44. M Alimohammadi, P Björklund, A Hallgren, et al. (2008) Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen. N Engl J Med 358 1018-1028.
45. A Falorni, S Laurenti and F Santeusanio (2002) Autoantibodies in autoimmune polyendocrine syndrome type II. Endocrinol Metab Clin North Am 31 369-389.
46. S Laureti, L Vecchi, F Santeusanio, et al. (1999) Is the prevalence of Addison's disease underestimated? J Clin Endocrinol Metab 84 1762.
47. GS Eisenbarth, PN Wilson, F Ward, et al. (1979) The polyglandular failure syndrome: disease inheritance, HLA-type, and immune function studies in patients and families. Ann Intern Med 91 528-533.
48. P Peterson, R Uibo and KJ Krohn (2000) Adrenal autoimmunity: results and developments. Trends Endocrinol Metab 11 285-290.
49. J Partanen, P Peterson, P Westman, et al. (1994) Major histocompatibility complex class II and III in Addison's disease: MHC alleles do not predict autoantibody specificity and 21-hydroxylase gene polymorphism has no independent role in disease susceptibility. Hum Immunol 41 135-140.
50. S Ten, M New and N MacLaren (2001) Clinical review 130: Addison's disease. J Clin Endocrinol Metab 86 2909-2922.
51. RS Wildin and A Freitas (2005) IPEX and FOXP3: clinical and research perspectives. J Autoimmun 25 56-62.
52. GA Sarosi, DW Voth, BA Dahl, et al. (1971) Disseminated histoplasmosis: results of long term follow-up. Ann Intern Med 75 511-516.
53. E Levine (1991) CT evaluation of active adrenal histoplasmosis. Urol Radiol 13 103-106.
54. SR Osa, RE Peterson and RB Roberts (1981) Recovery of adrenal reserve following treatment of South American blastomycosis. Am J Med 71 298-301.
55. RS Abernathy and JC Melby (1962) Addison's disease in North American blastomycosis. N Engl J Med 266 552-554.
56. BJ Glasgow, BS Steinsapir, K Anders, et al. (1985) Adrenal pathology in the acquired immunodeficiency syndrome. Am J Clin Pathol 84 594-597.
57. I Guerra and PL Kimmel (1991) Hypokalemic adrenal crisis in a patient with AIDS. South Med J 84 1265-1267.
58. N Arik, I Tasdemir, Y Karaaslan, et al. (1990) Subclinical adrenocortical insufficiency in renal amyloidosis. Nephron 56 246-248.
59. RI Hasan, NA Yonan and RA Lawson (1991) Adrenal insufficiency due to bilateral metastases from oat cell carcinoma of the esophagus. Eur J Cardiothorac Surg 5 336-337.
60. MA Satta, SM Corsello, S Della Casa, et al. (2000) Adrenal insufficiency as the first clinical manifestation of the primary antiphospholipid antibody syndrome. Clin Endocrinol (Oxf) 52 123-126.
61. B Feurstein and DHF Streeten (1991) Recovery of adrenal function after failure resulting from traumatic bilateral adrenal hemorrhages. Ann Intern Med 115 785-786.
62. MI New (1998) Diagnosis and management of congential adrenal hyperplasia. Annu Rev Med 49 311-328.
63. D Lin, T Sugawara, JF Strauss, et al. (1995) Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 267 1828-1831.
64. H Schaumberg, JM Powers, CS Raine, et al. (1975) Adrenoleukodystrophy: a clinical and pathological study of 17 cases. Arch Neurol 32 577-585.
65. AB Johnson, HH Ascauhberg and TM Powers (1976) Histochemical characteristics of the striated inclusions of adrenoleukodystrophy. J Histochem Cytochem 24 725-730.
66. JW Griffen, E Goren and H Schaumberg (1977) Adrenomyelopathy: a probable variant of adrenoleukodystrophy. Neurology 27 1107-1111.
67. H Schaumberg, JM Powers and CS Raine (1977) Adrenomyeloneuropathy: general, pathologic, neuropathologic, and biochemical aspects. Neurology 27 1114-1120.
68. S Laureti, G Casucci, F Santeusanio, et al. (1996) X-linked adrenoleukodystrophy is a frequent cause of idiopathic Addison disease in young adult male patients. J Clin Endocrinol Metab 81 470-474.
69. J Mosser, AM Douar, CO Sarde, et al. (1993) Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature 361 726-730.
70. P Aubourg, S Blanche, I Jambaquë, et al. (1990) Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation. N Engl J Med 322 1860-1866.
71. DG Morris, B Kola, N Borboli, et al. (2003) Identification of ACTH receptor mRNA in the human pituitary and its loss of expression in pituitary adenomas. J Clin Endocrinol Metab 88 6080-6087.
72. AJ Clark, L McLoughlin and A Grossman (1993) Familial glucocorticoid deficiency associated with point mutation in the adrenocorticotropin receptor. Lancet 341 461-462.
73. AJ Clark and A Weber (1998) Adrenocorticotropin insensitivity syndromes. Endocr Rev 19 828-843.
74. LA Metherell, JP Chapple, S Cooray, et al. (2005) Mutations in MRAP, encoding a novel interacting partner of the ACTH receptor, cause Familial Glucocorticoid Deficiency Type 2. Nat Genet 37 166-170.
75. AJL Clark, LA Metherell, ME Cheetham, et al. (2005) Inherited ACTH insensitivity illuminates the mechanisms of ACTH action. Trends Endocrinol Metab 16 451-457.
76. A Tullio-Pelet, R Salomon, S Hadj-Rabia, et al. (2000) Mutant WD-repeat protein in triple-A Syndrome. Nat Genet 26 332-335.
77. K Handschug, S Sperling, S-JK Yoon, et al. (2001) Triple A syndrome is caused by mutations in AAAs, a new WD-repeat protein gene. Hum Mol Genet 10 283-290.
78. H Houlden, S Smith, M de Carvalho, et al. (2002) Clinical and genetic characterisation of families with triple A (Allgrove) syndrome. Brain 25 2681-2690.
79. JK Phelan and ER McCabe (2001) Mutations in NR0B1 (DAX1) and NR5A1 (SF1) responsible for adrenal hypoplasia congenital. Hum Mutat 18 472-487.
80. AT Reutens, JC Achermann, M Ito, et al. (1999) Clinical and functional effects of mutations in DAX-1 gene in patients with adrenal hypoplasia congenital. J Clin Endocrinol Metab 84 504-511.
81. L Lin and JC Achermann (2004) Inherited adrenal hypoplasia: Not just for kids!. Clin Endocrinol (Oxf) 60 529-537.
82. AL Graber, RL Ney, WE Nicholson, et al. (1965) Natural history of pituitary-adrenal recovery following long-term suppression with corticosteroids. J Clin Endocrinol Metab 25 11-17.
83. RCD Staughten and PJ August (1975) Cushing's syndrome and pituitary-adrenal suppression due to clobetasol propionate. Br Med J 2 419-421.
84. V Hug, S Kau, GN Hertobagi, et al. (1991) Adrenal failure in patients with breast carcinoma after long-term treatment of cyclic alternating oestrogen progesterone. Br J Cancer 63 454-456.
85. R Comtois, H Beauregard, M Somma, et al. (1991) The clinical and endocrine outcome to transsphenoidal microsurgery of non-secreting pituitary adenomas. Cancer 68 860-866.
86. TL Verhage, MH Godfried and C Alberts (1990) Hypothalamic-pituitary dysfunction with adrenal insufficiency and hyperprolactinemia in sarcoidosis. Sarcoidosis 7 139-141.
87. FL Erdkamp, RO Gams and SJ Hoorntje (1991) Endocrine organ failure due to systemic AA-amyloidosis. Neth J Med 38 24-28.
88. SL Asa, JM Bilbao, K Kovacs, et al. (1981) Lymphocytic hypophysitis of pregnancy resulting in hypopituitarism: a distinct clinicopathologic entity. Ann Intern Med 95 166-171.
89. R Mirakian, AG Cudworth, GF Bottazzo, et al. (1982) Autoimmunity to anterior pituitary cells and the pathogenesis of insulin-dependent diabetes mellitus. Lancet 1 755-759.
90. A Bellastella, A Bizzarro, C Coronella, et al. (2003) Lymphocytic hypophysitis: a rare or underestimated disease? Eur J Endocrinol 149 363-376.
91. AM Pulichino, S Vallette-Kasic, C Couture, et al. (2003) Human and mouse TPIT gene mutations cause early onset pituitary ACTH deficiency. Genes Dev 15 711-716.
92. W Oelker (1989) Hyponatremia in inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism. N Engl J Med 321 492-496.
93. PM Zelissen (1994) Addison patients in the Netherlands: medical report of the survey. The Hague: Dutch Addison Society
94. W Oelkers (1996) Adrenal Insufficiency. N Engl J Med 335 1206-1212.
95. PM Stewart (2003) The adrenal cortex. PR Larsen, HM Kronenberg, S Melmed, et al., (Eds) Williams Textbook of Endocrinology Philadelphia, PA: Saunders 525-532.
96. B Allolio and W Arlt (2002) DHEA treatment: myth or reality? Trends Endocrinol Metab 13 288-294.
97. MS Claussen, J Landercasper and TH Cogbill (1992) Acute adrenal insufficiency presenting as shock after trauma and surgery: three cases and a review of the literature. J Trauma 32 94-100.
98. OH Pearson, WF Whitmore and CD West (1953) Clinical and metabolic studies of bilateral adrenalectomy for advanced cancer in man. Surgery 34 543-552.
99. MB Lipsett and OH Pearson (1956) Pathophysiology and treatment of adrenal crisis. N Engl J Med 254 511-515.
100. T Boykin, A DeTorrente and A Erikson (1978) The role of plasma vasopressin in impaired water excretion of glucocorticoid deficiency. J Clin Invest 62 738-746.
101. H Kehlet and C Binder (1973) Value of an ACTH test in assessing hypothalamic-pituitary-adrenocortical function in glucocorticoid-treated patients. Br Med J 2 147-152.
102. JJ Mukherjee, J Jacome de Castro, G Kaltsas, et al. (1997) A comparison of insulin tolerance/glucagon tests with the short ACTH stimulation test for assessment of hypothalamo-pituitary-adrenal axis in the early post-operative period after hypophysectomy. Clin Endocrinol (Oxf) 47 51-60.
103. M Calis, C Gokce, F Ates, et al. (2004) Investigation of the hypothalamo-pituitary-adrenal axis (HPA) by 1 microg ACTH test and metyrapone test in patients with primary fibromyalgia syndrome. J Endocrinol Invest 27 42-46.
104. S Rasmuson, T Olsson and E Hagg (1996) A low dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol (Oxf) 44 151-156.
105. SL Jones, PJ Trainer, L Perry, et al. (1994) An audit of the insulin tolerance test in adult subjects in an acute invesigation unit over one year. Clin Endocrinol 41 123-128.
106. C Betterle, M Volpato, B Pedini, et al. (1999) Adrenal-cortex autoantibodies and steroid-producing cells autoantibodies in patients with Addison's disease: comparison of immunofluorescence and immunoprecipitation assays. J Clin Endocrinol Metab 84 618-622.
107. H Kehlet, SN Madsen and C Binder (1974) Cortisol and cortisone acetate in parenteral glucocorticoid therapy. Acta Med Scand 195 421-425.
108. BL Fariss, S Hane and H Shinsako (1978) Comparison of absorption of cortisone acetate and hydrocortisone hemisuccinate. J Clin Endocrinol Metab 47 1137-1140.
109. SJK Baker, PJ Hunt and JAH Wass (1997) Assessing the potential for fine tuning the management of Addison's disease/steroid replacement therapy. 188th Society for Endocrinology (UK) meeting, London. J Endocrinol Abstract Suppl 155 P2.
110. K Lovas, JH Loge and ES Husebye (2002) Subjective health status in Norwegian patients with Addison's disease. Clin Endocrinol (Oxf) 56 581-588.
111. W Arlt, F Callies, JC van Vlijmen, et al. (1999) Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 341 1013-1020.
112. PJ Hunt, EM Gurnell, FA Huppert, et al. (2000) Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. J Clin Endocrinol Metab 85 4650-4656.
113. K Lovas, G Gebre-Medhin, TS Trovik, et al. (2003) Replacement of dehydroepiandrosterone in adrenal failure: no benefit for subjective health status and sexuality in a 9-month, randomized, parallel group clinical trial. J Clin Endocrinol Metab 88 1112-1118.
114. EM Gurnell, PJ Hunt, SE Curran, et al. (2008) Long term DHEA replacement in primary adrenal insufficiency: a randomized, controlled trial. J Clin Endcrinol Metab 93 400-409.
115. R Udelsman, GP Chrousos and DL Loriaux (1986) Adaptation during surgical stress. J Clin Invest 77 1377-1381.
116. MS Cooper and PM Stewart (2003) Corticosteroid insufficiency in acutely ill patients. N Engl J Med 348 727-734.
117. BM Arafah (2004) Review: hypothalamic pituitary adrenal function during critical illness: limitations of current assessment methods. J Clin Endocrinol Metab 91 3725-3745.
118. AH Hamrahian, TS Oseni and BM Arafah (2004) Measurements of serum free cortisol in critically ill patients. N Engl J Med 350 1629-1638.
119. JT Ho, H Al-Musalhi, MJ Chapman, et al. (2006) Septic shock and sepsis: a comparison of total and free plasma cortisol levels. J Clin Endocrinol Metab 91 105-114.
120. L Loriaux (2004) Glucocorticoid therapy in the intensive care unit. N Engl J Med 350 1601-1602.
121. JA Russell (2006) Management of sepsis. N Engl J Med 355 1699-1713.
122. The Veterans Administration Systemic Sepsis Cooperative Study Group (1987) Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. N Engl J Med 317 659-665.
123. RC Bone, CJ Fisher Jr, TP Clemmer, et al. (1987) A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 317 653-658.
124. D Annane, V Sebille, C Charpentier, et al. (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288 862-871.
125. CL Sprung, D Annane, D Keh, et al. (2008) for the CORTICUS Study Group: hydrocortisone therapy for patients with septic shock. N Engl J Med 358 111-124.
126. Surviving Sepsis Campaign. http://www.survivingsepsis.org